pharm-analyt − Leading Lab in PEG Analysis

After having completed another method establishment for a Polyethylenglycol (PEG) recently, pharm-analyt continues to be a leading lab in PEG analysis. Quantitative analysis has always been the main pillar for pharm-analyt for over
3 decades of operation.

Starting in 1986 with bioanalysis and HPLC-UV nowadays GMP release analysis and HPLC-MS/MS are at the core of pharm-analyt's activities. With only 20 people being employed at pharm-analyt we have kept our flexibility in order to solve analytical challenges and more recently also consistently keep timelines.

Quantifying PEGylated substances has been a specialty for more than a decade becoming a core competence in the last 2 years. At the moment pharm-analyt serves 4 different clients with quantitative analysis of PEGs and has methods to determine altogether 6 current pegylated substances in the range of 4 to 60 kDa.

pharm-analyt has covered PEG determination in the biological matrices rat/human plasma/CSF and FDP/FC/BDS formulations, always going in the direction of using stable labelled internal standards.

The most refined and up-to-date method has a calibration range of 20 to 1,000 ng/mL for a more than 30 kDa PEG in plasma with a calibration curve that is linear.

We are good at analysing various peptides, mycotoxins and anthracyclines which makes us a valued provider for the pharmaceutical industry especially in oncology/chemotherapy. However, amazement you would only experience with the PEG analytical competence and metaknowledge you will find at pharm-analyt.

Send us your quantitative analytical problem with a PEG over, you will have a 95 % chance that we will have a solution within short time.

> 30 kDa Free PEG in Plasma
Calibration range 20.0 – 1,000 ng/mL
Upper chrom Std at LLOQ
Lower chrom internal standard
HPLC-MS/MS

Meet our Founder at Rare 2018 in London!

Hermann is well known in the community, as he found several biomarkers for rare lysosomal diseases e.g. Fabry, Gaucher, NP-C, MLD.

Meet our new head of Business Development@BIO-EUROPE in Berlin!

Reinhard received a PhD in Clinical Pharmacology from the University of Vienna (thesis about development of a multi compound HPLC method with semi-automated SPE). He has a long time experience in selling chromatography disposables, instruments and services within Europe.

His goal as the head of business development at pharm-analyt is to work closely with clients for a better understanding for the future needs in the market.

14.00 Derivatisierungsfreier Nachweis von Östrogenen in Plasma im untersten pg/ml Bereich mittels Ionen Mobilität auf einem High-End-QTRAP System, Prof. Hermann Mascher

It has been quite a hot period for us between summer 2015 and summer 2016 here at pharm-analyt. Due to capacity improvements in documentation we have been able to close many projects by fall 2016. The winter season appears to be cooler, for us also in terms of business, and we are anticipating excess capacity between December 2016 and February 2017.

However, we are not even considering hibernating!

Rather, we invite you to join our seasonal promotion: If you order one of the two packages gingerbread or mistletoe between 1 December 2016 and 28 February 2017 you will benefit from our promotional package prices. The GLP assays qualifying for the packages are displayed in a table below:

List of GLP Assays Eligible for Bioanalytical Winter Promotion

 
Note: This is only a small fraction of pharm-analyt's assays